Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma
出版年份 2020 全文链接
标题
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma
作者
关键词
-
出版物
Science Signaling
Volume 13, Issue 619, Pages eaax8238
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2020-02-19
DOI
10.1126/scisignal.aax8238
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts
- (2019) Yuanhang Liu et al. Scientific Reports
- FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
- (2019) Carlos J Diaz Osterman et al. eLife
- Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer
- (2018) Mathieu Unbekandt et al. CANCER RESEARCH
- Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer
- (2018) Angela Musella et al. CANCER TREATMENT REVIEWS
- Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
- (2018) Stephen J. Pettitt et al. Nature Communications
- Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
- (2018) Philipp M. Cromm et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer
- (2017) Tessa Humphries-Bickley et al. MOLECULAR CANCER THERAPEUTICS
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status
- (2016) F. Coscia et al. Nature Communications
- Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
- (2016) James Campbell et al. Cell Reports
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
- (2015) Yu Yu et al. CANCER CELL
- The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration
- (2015) Vijay Pralhad Kale et al. CANCER LETTERS
- Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells
- (2015) T Y Prudnikova et al. ONCOGENE
- Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells
- (2015) Qi Zhou et al. MEDICAL SCIENCE MONITOR
- A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion
- (2014) Vijay Pralhad Kale et al. CANCER LETTERS
- A novel small-molecule MRCK inhibitor blocks cancer cell invasion
- (2014) Mathieu Unbekandt et al. Cell Communication and Signaling
- The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer
- (2014) Mathieu Unbekandt et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Evaluating Strategies to Normalise Biological Replicates of Western Blot Data
- (2014) Andrea Degasperi et al. PLoS One
- The dynamic nature of the kinome
- (2013) Lee M. Graves et al. BIOCHEMICAL JOURNAL
- Characterization of the Novel Broad-Spectrum Kinase Inhibitor CTx-0294885 As an Affinity Reagent for Mass Spectrometry-Based Kinome Profiling
- (2013) Luxi Zhang et al. JOURNAL OF PROTEOME RESEARCH
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer
- (2012) A. A. Secord et al. CLINICAL CANCER RESEARCH
- EGFR/HER-targeted therapeutics in ovarian cancer
- (2012) Jason A Wilken et al. Future Medicinal Chemistry
- Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles
- (2012) Sally J. Deeb et al. MOLECULAR & CELLULAR PROTEOMICS
- Primary culture and immortalization of human fallopian tube secretory epithelial cells
- (2012) Alison M Karst et al. Nature Protocols
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
- (2011) Matthew P. Patricelli et al. CHEMISTRY & BIOLOGY
- c-Cbl Ubiquitin Ligase Regulates Focal Adhesion Protein Turnover and Myofibril Degeneration Induced by Neutrophil Protease Cathepsin G
- (2011) Khadija Rafiq et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Super-SILAC for tumors and tissues
- (2010) Thomas A Neubert et al. NATURE METHODS
- Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
- (2010) B. W. Murray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Large-scale Proteomics Analysis of the Human Kinome
- (2009) Felix S. Oppermann et al. MOLECULAR & CELLULAR PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started